As per my knowledge, as sertraline alpha carbon have non-aromatic ring and alpha carbon part of ring. Hence, AF-score, we have to consider non-aromatic ring and alpha carbon part of ring also.
Please let me know for clarity.
N-nitroso-sertraline is included as EMA Example 7. It clearly shows alpha carbon which is part of the ring and bonds to an aromatic ring is considered one of Activating Features.
As far as the case of the cycline, deactivating feature “hydroxyl group bonded to β-carbon*** on only one side of N-nitroso group (cyclic or acyclic)” has the footnote of “***β-Carbon must be in an sp3 hybridization state for this feature to apply.” Therefore OH in cycline compounds is not considered as the deactivating feature.
Dear all,
Great tool! Thanks.
Regarding the α-hydrogen score (table 2 in EMA Q&A, table A in FDA guideline), I am not sure I understand and interpret correctly the note for the first row: “A score of 3 applies when the methylene α-carbon is not part of an ethyl group. If the methylene α-carbon is part of an ethyl group, a score of 2 should be applied”.
Do they mean unsubstituted ethyl group only? For example I have a substituted ethylether next to nitroso group, would that give a score of 2 or 3?
Many thanks in advance for your help.
Do they mean unsubstituted ethyl group only? For example I have a substituted ethylether next to nitroso group, would that give a score of 2 or 3?
It means only the unsubstituted ethyl group. The ethyl ether next to the nitroso group gives a score of 3. The following calculator may be helpful for using CPCA.
Hi, including potency score for one of the NDSRI as provided in pic above, could anyone guide on correctness specially for N-nitroso group in a 5-or6 membered ring as this does not includes the examples provided in USFDA guidance.
thanks in advance